Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,056 | 11,797 | 14,323 | 14,163 | 17,880 |
| Marketable Securities | 15,200 | 22,663 | 25,111 | 30,437 | 31,415 |
| TOTAL | $31,889 | $36,918 | $41,290 | $45,343 | $50,151 |
| Non-Current Assets | |||||
| PPE Net | 5 | 8 | 12 | 16 | 29 |
| Intangibles | 137 | 852 | 558 | 423 | 471 |
| TOTAL | $142 | $860 | $570 | $439 | $500 |
| Total Assets | $32,031 | $37,778 | $41,860 | $45,782 | $50,651 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 382 | 184 | 797 | 438 | 512 |
| Accrued Expenses | 2,441 | 3,204 | 1,573 | 1,647 | 1,850 |
| Other current liabilities | 27,349 | 30,078 | 70,798 | 27,782 | 30,430 |
| TOTAL | $30,172 | $33,466 | $73,168 | $29,867 | $32,792 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 20 | 30 |
| TOTAL | $N/A | $N/A | $N/A | $20 | $30 |
| Total Liabilities | $30,172 | $33,466 | $73,168 | $29,887 | $32,822 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101 | 100 | 100 | 100 | 100 |
| Common Shares | 14 | 140 | 140 | 140 | 140 |
| Retained earnings | -513,474 | -510,241 | -545,107 | -497,155 | -494,771 |
| TOTAL | $1,859 | $4,312 | $-31,308 | $15,895 | $17,829 |
| Total Liabilities And Equity | $32,031 | $37,778 | $41,860 | $45,782 | $50,651 |